mbiomics
GermanyEntry
2023
Hold
3yr
Status
Active
Who owns mbiomics?
mbiomics is a German Biotech company, currently owned by Bayern Kapital since 2023 and 2 other investors.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
High-Tech Gruenderfonds (HTGF)HTGF IV · 2022 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2023 · present
Bayern KapitalActive
2023 · present(3yr) · Seedfonds Bayern · 1996 · VC
MIG CapitalActive
2023 · present(3yr) · MIG Fonds 16 · 2019 · Evergreen
More from HTGF IV
Other portfolio companies in the same fund.
Switzerland
Denmark
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns mbiomics?
mbiomics is currently owned by Bayern Kapital, MIG Capital and 1 other, through HTGF IV, since 2023.
When did Bayern Kapital and 2 others acquire mbiomics?
Bayern Kapital and 2 others acquired mbiomics in 2023.
Who has owned mbiomics over time?
mbiomics has been through 3 private-equity ownership periods: Bayern Kapital · via Seedfonds Bayern · since 2023; MIG Capital · via MIG Fonds 16 · since 2023; High-Tech Gruenderfonds (HTGF) · via HTGF IV · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue